No Data
No Data
Express News | ITeos Therapeutics Shares Are Trading Higher After the Company Announced the Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
Express News | ITeos Therapeutics Announces Interim Data From GALAXIES Lung-201 Study Sponsored By Partner GSK Will Be PREsented At Society For Medical Oncology Congress 2024
Express News | Iteos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 Galaxies Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
J.P. Morgan Sticks to Its Buy Rating for ITeos Therapeutics (ITOS)
ITeos Therapeutics Initiated at Overweight by Wells Fargo
Wells Fargo Initiates ITeos Therapeutics(ITOS.US) With Buy Rating, Announces Target Price $31